Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7808
Peer-review started: January 4, 2022
First decision: March 12, 2022
Revised: March 22, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: August 6, 2022
Processing time: 199 Days and 11.9 Hours
Chronic pancreatitis (CP) is a long-lasting disease frequently associated with complications for which there exists so far no comprehensive pathophysiological classification.
The motivation of present study was: To propose a pathophysiological classification of the complications of CP; evaluate their prevalence in a surgical cohort prior to, and following surgical management; and assess the impact of the surgical treatment on the occurrence of new complications of CP during follow-up.
To describe the full diversity of severe complications of CP seen in our cohort during 20 years of study using proposed classification of complications of CP; and to assess the impact of surgical treatment on the development of new complications during follow-up.
After institutional review board approval, a prospective observational cohort study with long-term follow-up (up to 20.4 years) was conducted. All consecutive single-center adult patients (≥ 18 years of age) with CP according to the criteria of the American Pancreas Association subjected to surgical management between 1997 and 2021, were included. The prevalence of the complications of CP was evaluated, according to the proposed classification, in a surgical cohort of 166 patients.
We distinguished four groups of complications: Pancreatic duct complications, peripancreatic complications, pancreatic hemorrhages, and pancreatic insufficiency (exocrine and endocrine). Their baseline prevalence was 20.5%, 23.5%, 10.2%, 31.3% and 27.1%, respectively. Surgical treatment was highly effective in avoiding new complications in the first and third groups. In the group of peripancreatic complications, the 15-year Kaplan-Meier prevalence of new complications was 12.1%. The prevalence of pancreatic exocrine and endocrine insufficiency increased during follow-up, being 66.4% and 47.1%, respectively, 15 years following surgery.
The proposed complication classification improves the understanding of CP. It could be beneficial for clinical decision making, as it provides an opportunity for more comprehensive judgement on patient’s needs on the one hand, and on the pros and cons of the treatment under consideration, on the other. The presence of the complications of CP and the risk of development of new ones should be among main determinants of surgical choice.
It would be interesting to compare the effectiveness of the surgical and endoscopic treatment of complications of CP using our proposed classification.